Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Atacand: new antihypertensive agent approved for marketing in U.S.

June 8, 1998

Profile of activity of CGS-26582, a triple inhibitor of ECE, NEP and ACE

June 8, 1998

Posicor voluntarily withdrawn from the market

June 8, 1998

Preclinical and clinical profile of lercanidipine detailed at recent congress

June 5, 1998

Cardioprotective properties found for pranidipine, a long-acting Ca antagonist

June 5, 1998

Candesartan reduces infarct size in pig model of myocardial ischemia

June 5, 1998

Reversal of diabetes-induced cardiac fibrosis with pirfenidone obtained in animal model

June 5, 1998

Pharmacological profile of a selective ETA antagonist

June 5, 1998

TA-606, an orally active prodrug of the potent AII antagonist 606A

June 4, 1998

Chinese herbal drug tetramethylpyrazine inhibits ET-1-induced vasoconstriction

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...